One-year outcomes of intravitreal conbercept combined rescue therapy for polypoidal choroidal vasculopathy in a Chinese population: a real-life clinical data [PDF]
International Journal of Ophthalmology, 2019 AIM: To evaluate the real-life clinical outcomes of intravitreal injection of conbercept combined rescue therapy for polypoidal choroidal vasculopathy (PCV). METHODS: This was an open label, single center, and interventional study. All enrolled patients
Hui-Jun Qi, En-Zhong Jin, Ming-Wei Zhao
doaj +1 more source
Short-term effects of intravitreal Conbercept injection combined with laser photocoagulation on macular edema secondary to ischemic retinal vein occlusion [PDF]
International Journal of Ophthalmology, 2021 AIM: To observe changes in the best-corrected visual acuity (BCVA), central macular thickness (CMT), and central choroidal thickness (CCT) of patients with macular edema (ME) secondary to ischemic retinal vein occlusion (iRVO) following intravitreal ...
Zheng-Feng Liu +6 more
doaj +1 more source
Pharmacokinetic Simulations of Intravitreal Biologicals : Aspects of Drug Delivery to the Posterior and Anterior Segments [PDF]
, 2018 Biologicals are important ocular drugs that are be delivered using monthly and bimonthly intravitreal injections to treat retinal diseases, such as age-related macular degeneration. Long acting delivery systems are needed for prolongation of their dosing
Deng, Feng +4 more
core +1 more source
Scientific Reports, 2017 The novel anti-VEGF drug conbercept has been used in the treatment of several retinal neovascular diseases. Owning to the alteration of the structure, the newest drug is capable of combining more molecular targets and present higher affinity to the ...
Jiaming Wang +6 more
doaj +1 more source
Anti-VEGF Therapy in Myopic CNV [PDF]
, 2021 In this narrative-review, we report the most recent data from the literature of anti-vascular endothelial growth factor treatment for myopic choroidal neovascularization (mCNV). Myopic CNV is the most frequent sight-threatening complication of pathologic
Lisa Toto +3 more
core +1 more source
BMC Ophthalmology, 2021 Background The use of Spectral domain optical coherence tomography (SD-OCT) to evaluate the predictors of visual acuity-recovery in patients treated with conbercept for macular edema (ME) secondary to central retinal vein occlusion (CRVO) has rarely been
Qi Zhang +8 more
doaj +1 more source
Comprehensive evaluation of intravitreal conbercept versus half-dose photodynamic therapy for chronic central serous chorioretinopathy [PDF]
International Journal of Ophthalmology, 2021 AIM: To compare the safety and efficacy of conbercept intravitreal injection and half-dose photodynamic therapy (PDT) in treating chronic central serous chorioretinopathy (CSC). METHODS: This study was retrospective.
Jian-Bo Mao +9 more
doaj +1 more source
Intravitreous injection of conbercept for bullous retinal detachment: A case report
World Journal of Clinical Cases, 2022 Diffuse retinal pigment epitheliopathy (DRPE) associated with bullous retinal detachment is a severe variant of DRPE that is frequently misdiagnosed and often improperly treated.A 36-year-old female patient complained of "painless vision decline in the left eye with obscuration for 10 d".
Xiang, Xiao-Li +3 more
openaire +2 more sources
Characterizing Flow and Structure of Diabetic Retinal Neovascularization after Intravitreal Anti-VEGF Using Optical Coherence Tomography Angiography: A Pilot Study [PDF]
, 2021 Background/Aims. This study evaluates changes of flow and structure of diabetic retinal neovascularization (NV) treated with intravitreal antivascular endothelial growth factor (VEGF) agents using optical coherence tomography angiography (OCTA).
Barthelmes, Daniel +3 more
core +1 more source
Recent advancements in the medical treatment of diabetic retinal disease [PDF]
, 2021 Diabetic retinal disease remains one of the most common complications of diabetes mellitus (DM) and a leading cause of preventable blindness. The mainstay of management involves glycemic control, intravitreal, and laser therapy.
Cordeiro, MF +3 more
core +2 more sources